Human IGG1 monoclonal antibody specific for human interleukin-1 alpha XBiotech Európai Unió - magyar - EMA (European Medicines Agency)

human igg1 monoclonal antibody specific for human interleukin-1 alpha xbiotech

xbiotech germany gmbh - humán igg1 monoklonális antitest, amely humán interleukin-1 alfa-specifikus - colorectalis daganatok - daganatellenes szerek - kezelés a metasztatikus colorectalis rák.

PalaMOUNTAINS REPALA Body Spray Testpermet kutyáknak, macskáknak, lovaknak Magyarország - magyar - NÉBIH (Nemzeti Élelmiszerlánc-biztonsági Hivatal)

palamountains repala body spray testpermet kutyáknak, macskáknak, lovaknak

vitapower ltd. - kutyaparvovírus (cpv) canine parvovirus, live - külsoleges oldatos spray - canine parvovirus vaccine - ló, kutya, macska

Oropharma Body Clean törlokendo Magyarország - magyar - NÉBIH (Nemzeti Élelmiszerlánc-biztonsági Hivatal)

oropharma body clean törlokendo

bfb plus mezogazdasági, termeloi és kereskedelmi kft. - külsoleges oldat - kutya, macska

Flebogamma DIF (previously Flebogammadif) Európai Unió - magyar - EMA (European Medicines Agency)

flebogamma dif (previously flebogammadif)

instituto grifols s.a. - a humán normál immunglobulin - mucocutaneous lymph node syndrome; guillain-barre syndrome; bone marrow transplantation; purpura, thrombocytopenic, idiopathic; immunologic deficiency syndromes - immunrendszer sera, immunglobulinok, - replacement therapy in adults, children and adolescents (0-18 years) in: , primary immunodeficiency syndromes with impaired antibody production;, hypogammaglobulinaemia and recurrent bacterial infections in patients with chronic lymphocytic luekaemia, in whom prophylactic antibiotics have failed;, hypogammaglobulinaemia and recurrent bacterial infections in plateau-phase-multiple-myeloma patients who failed to respond to pneumococcal immunisation;, hypogammaglobulinaemia in patients after allogenic haematopoietic-stem-cell transplantation (hsct);, congenital aids with recurrent bacterial infections. , immunomodulation in adults, children and adolescents (0-18 years) in: , primary immune thrombocytopenia (itp), in patients at high risk of bleeding or prior to surgery to correct the platelet count;, guillain barré syndrome;, kawasaki disease.

Vyvgart Európai Unió - magyar - EMA (European Medicines Agency)

vyvgart

argenx - efgartigimod alfa - myasthenia gravis - immunszuppresszánsok - vyvgart is indicated as an add on to standard therapy for the treatment of adult patients with generalised myasthenia gravis (gmg) who are anti acetylcholine receptor (achr) antibody positive.